EA200200493A1 - Способ получения композиции для лечения, ухода и защиты кожи детей и взрослых - Google Patents

Способ получения композиции для лечения, ухода и защиты кожи детей и взрослых

Info

Publication number
EA200200493A1
EA200200493A1 EA200200493A EA200200493A EA200200493A1 EA 200200493 A1 EA200200493 A1 EA 200200493A1 EA 200200493 A EA200200493 A EA 200200493A EA 200200493 A EA200200493 A EA 200200493A EA 200200493 A1 EA200200493 A1 EA 200200493A1
Authority
EA
Eurasian Patent Office
Prior art keywords
melted
paraffin oil
until completely
children
care
Prior art date
Application number
EA200200493A
Other languages
English (en)
Other versions
EA003903B1 (ru
Inventor
Воислав Павлович
Original Assignee
Воислав Павлович
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Воислав Павлович filed Critical Воислав Павлович
Publication of EA200200493A1 publication Critical patent/EA200200493A1/ru
Publication of EA003903B1 publication Critical patent/EA003903B1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)

Abstract

Способ получения композиции для лечения, ухода и защиты кожи детей и взрослых, заключающийся в том, что порошок окиси цинка в количестве 0,4 г и порошок талька в количестве 0,6 г смешивают с 1 г вазелинового масла в течение 1-2 мин до полной однородности. Ланолин в количестве 27 г, вазелин в количестве 23 г, вазелиновое масло в количестве 11 г, дистиллированную воду в количестве 10 г, порошок борной кислоты в количестве 4 г и миндальную воду в количестве 8 г помещают в металлическую емкость и плавят на водяной бане при температуре приблизительно 65°С до полного расплавления. Когда компоненты расплавляются, нагревание прекращают и медленно при постоянном перемешивании добавляют однородную смесь, состоящую из окиси цинка, порошка талька и масла парафина, до полной гомогенизации. Композицию, полученнаю данным способом, охлаждают и в результате получают мягкую желтоватую мазь с мягким запахом миндаля.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200493A 1999-10-26 1999-10-26 Способ получения композиции для лечения, ухода и защиты кожи детей и взрослых EA003903B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/YU1999/000009 WO2001030363A1 (en) 1999-10-26 1999-10-26 A procedure for obtaining a zinc oxide containing product for skin-healing, care and protection in children and adults

Publications (2)

Publication Number Publication Date
EA200200493A1 true EA200200493A1 (ru) 2002-10-31
EA003903B1 EA003903B1 (ru) 2003-10-30

Family

ID=25559988

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200493A EA003903B1 (ru) 1999-10-26 1999-10-26 Способ получения композиции для лечения, ухода и защиты кожи детей и взрослых

Country Status (6)

Country Link
EP (1) EP1455805B1 (ru)
AT (1) ATE362370T1 (ru)
AU (1) AU6434199A (ru)
DE (1) DE69936107T2 (ru)
EA (1) EA003903B1 (ru)
WO (1) WO2001030363A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004093569A1 (en) * 2003-04-21 2004-11-04 Osman Fathi Osman Topical composition on the basis of honey
RS20080245A (en) * 2008-05-30 2010-03-02 Ljubica Pavlović Method for obtaining of the preparation for care and protection of skin with children and adults
ES2365972B1 (es) * 2010-03-30 2012-08-23 Laboratorios Ojer Pharma S.L. Composición para regeneración tisular.
CN106488698A (zh) * 2014-05-26 2017-03-08 加利福尼亚大学董事会 有机修剪伤口组合物
TR201715943A1 (tr) * 2017-10-17 2019-02-21 Moss Farma Ilac Itr Med Kozm Tib Cih Ith Ihr San Ve Tic A S Bi̇r ci̇lt bakim kremi̇ üreti̇m yöntemi̇
GR1009906B (el) * 2019-03-01 2021-01-13 Χριστινα Μοσχου Γκιουρδα Παστα για την προληψη και θεραπεια των κατακλισεων και συναφων ελκων και μεθοδος παραγωγης της
CN110775996A (zh) * 2019-09-30 2020-02-11 成都理工大学 一种滑石负载纳米ZnO复合抗紫外剂及其制备技术

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2631284A1 (de) * 1976-07-12 1978-01-26 Henkel Kgaa Kosmetische mittel mit einem gehalt an haut-feuchthaltemitteln
DE2704904A1 (de) * 1977-02-05 1978-08-10 Henkel Kgaa Kosmetische mittel mit einem gehalt an haut-feuchthaltemitteln
EP1374847A1 (en) * 1995-06-22 2004-01-02 Minnesota Mining And Manufacturing Company Stable hydroalcoholic compositions

Also Published As

Publication number Publication date
EP1455805B1 (en) 2007-05-16
EA003903B1 (ru) 2003-10-30
WO2001030363A1 (en) 2001-05-03
DE69936107D1 (de) 2007-06-28
DE69936107T2 (de) 2008-01-10
EP1455805A1 (en) 2004-09-15
AU6434199A (en) 2001-05-08
ATE362370T1 (de) 2007-06-15

Similar Documents

Publication Publication Date Title
ES2081927T3 (es) Metodo de revitalizar celulas antes de la crioconservacion.
DE3771039D1 (de) Therapeutisches mittel.
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
HK1040985A1 (en) Cell adhesion-inibiting antiinflammatory and immunesuppressive compounds.
EA200200493A1 (ru) Способ получения композиции для лечения, ухода и защиты кожи детей и взрослых
EP0108821A1 (en) Compositions for treating acne
JPS54160740A (en) Anti-fibrotic agent
ES482787A1 (es) Un procedimiento para preparar derivados de flavano, mono- di-y tri-sustituidos.
SE7601143L (sv) Nytt oxadiazolinonderivat
PE20001067A1 (es) Derivados de 2-fenilpiran-4-ona
US4017628A (en) Treatment of mange
ATE22685T1 (de) Substituierte 1,3-diazolyl-2-propanole, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel.
ATE16106T1 (de) Chroman-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE179424T1 (de) N-heteroaryl substituierte propanamid-derivate brauchbar zur behandlung cardiovascularer krankheiten
DE59905700D1 (de) N-phenylacetoacetamide und Verfahren zu ihrer Herstellung
YU37494A (sh) Postupak za dobijanje preparata za lečenje, negu i zaštitu kože dece i odraslih
US3952036A (en) 1,1-(Thiadialkylidene) ferrocene S-oxides
DE3175674D1 (en) Novel dibenzoxepins, their preparation, compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions
JPS572279A (en) Dibenzoxazepin derivative
Herbrandson et al. Cyclic disulfides. II. 1, 2-Dithiepan-5-amine
RU96122032A (ru) Болеутоляющие ректальные свечи и способ их получения
FR2566407B1 (fr) Nouveaux derives de l'isoxazoloquinoleine, procede de preparation, application a titre de medicaments, et compositions les renfermant
SU679545A1 (ru) Состав дл изготовлени строительных изделий
Mann CCLXI.—The interaction of aniline and acraldehyde
ATE232195T1 (de) Verfahren zur herstellung von calciumpyruvaten

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU